- Home
- ACHR vs VKTX Comparison
ACHR vs VKTX Comparison
Compare ACHR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHR | VKTX |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ACHR | VKTX |
|---|---|---|
| Price | $4.15 | $27.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 21 |
| Target Price | $10.89 | ★ $95.32 |
| AVG Volume (30 Days) | ★ 19.6M | 4.8M |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.28 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | $4,944.37 | N/A |
| Revenue Next Year | $812.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.68 | $23.82 |
| 52 Week High | $11.09 | $43.15 |
Technical Indicators
Market Signals| Indicator | ACHR | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 46.85 |
| Support Level | $3.68 | $26.47 |
| Resistance Level | $5.64 | $34.00 |
| Average True Range (ATR) | 0.23 | 1.53 |
| MACD | 0.06 | 0.27 |
| Stochastic Oscillator | 41.47 | 72.60 |
Price Performance
Historical ComparisonAbout ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner. The company is building a platform to deliver aircraft, technologies, and services to customers world-wide across commercial and defense sectors.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.